dihydrotestosterone has been researched along with Dyslipidemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Culig, Z; Madersbacher, S; Sampson, N | 1 |
Alexanderson, C; Anesten, F; Borén, J; De Gendt, K; Fagman, JB; Holmäng, A; Jansson, JO; Krettek, A; Levin, M; Motta, BM; Ohlsson, C; Pirazzi, C; Romeo, S; Tivesten, Å; Verhoeven, G; Wilhelmson, AS | 1 |
1 review(s) available for dihydrotestosterone and Dyslipidemia
Article | Year |
---|---|
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aging; Diabetes Mellitus; Dihydrotestosterone; Dutasteride; Dyslipidemias; Finasteride; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Prostatic Hyperplasia; Receptors, Androgen | 2019 |
1 other study(ies) available for dihydrotestosterone and Dyslipidemia
Article | Year |
---|---|
The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Diet; Dihydrotestosterone; Dyslipidemias; Fatty Liver; Female; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Orchiectomy; Ovariectomy; Receptors, Androgen | 2015 |